Home

Concord Biotech Ltd EPS

Image

Concord Biotech Ltd

NSE: CONCORDBIO

EPS

₹ 31.19

Last updated on: Feb 18, 2025

Key Highlights

  • The Earning per Share of Concord Biotech Ltd is ₹ 31.19 as of 18 Feb 25 .
  • The earning per share of Concord Biotech Ltd changed from ₹ 5.21 to ₹ 7.26 over 7 quarters. This represents a CAGR of 20.88% .

Historical Earning per Share of Concord Biotech Ltd

No data available

* All values are in

Company Fundamentals for Concord Biotech Ltd

Market Cap

18,450 Cr

EPS

31.2

P/E Ratio (TTM)

56.5

P/B Ratio (TTM)

11.6

Day’s High

1750.05

Day’s Low

1683.7

DTE

0.0

ROE

20.6

52 Week High

2658.0

52 Week Low

1326.9

ROCE

27.8

Market Price of Concord Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Concord Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
18 Feb 20251763.6
17 Feb 20251684
14 Feb 20251693.2
13 Feb 20252109.95
12 Feb 20252120.75
11 Feb 20252144.55
10 Feb 20252235.25
07 Feb 20252342.25
06 Feb 20252343.65
05 Feb 20252270.6

SWOT Analysis Of Concord Biotech Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Concord Biotech Ltd

Asset Value vs Market Value of Concord Biotech Ltd

Market Value

18,450

Asset Value

Value addition

27.2 X

655

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Concord Biotech Ltd18450
Sun Pharmaceuticals Industries Ltd408259
Divis Laboratories Ltd154917
Cipla Ltd119705
Torrent Pharmaceuticals Ltd103096
Dr Reddys Laboratories Ltd99951

Historical Market Cap of Concord Biotech Ltd

No data available

* All values are in crore

Historical Revenue of Concord Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Concord Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Concord Biotech Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Concord Biotech Ltd News Hub

Concord Biotech consolidated net profit rises 9.36% in the June 2024 quarter

Net profit of Concord Biotech rose 9.36% to Rs 59.59 crore in the quarter ended June 2024 as against

Read more

09 Aug 24

Volumes jump at Concord Biotech Ltd counter

K E C International Ltd, Sonata Software Ltd, TV18 Broadcast Ltd, ZF Commercial Vehicle Control Syst

Read more

29 Aug 24

Concord Biotech to conduct board meeting

Concord Biotech will hold a meeting of the Board of Directors of the Company on 11 November 2024 Pow

Read more

06 Nov 24

Concord Biotech consolidated net profit rises 18.17% in the September 2024 quarter

Net profit of Concord Biotech rose 18.17% to Rs 95.74 crore in the quarter ended September 2024 as a

Read more

11 Nov 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

FAQs for EPS of Concord Biotech Ltd

What is the EPS of Concord Biotech Ltd stock?

The Earnings Per Share (EPS) of Concord Biotech Ltd is 31.19. An EPS is the amount of net income attributed to each share of a common stock.

How is Concord Biotech Ltd EPS calculated?

The EPS of Concord Biotech Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Concord Biotech Ltd report its EPS?

Concord Biotech Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Concord Biotech Ltd EPS?

Factors that influence the EPS of Concord Biotech Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Concord Biotech Ltd EPS growth indicate future performance?

Yes, consistent growth in Concord Biotech Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions